Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Publication
, Journal Article
Baker, EK; Derry, A; Cohen, JL; Chang, IJ
Published in: Genetics in Medicine Open
January 1, 2025
Duke Scholars
Published In
Genetics in Medicine Open
DOI
EISSN
2949-7744
Publication Date
January 1, 2025
Volume
3
Citation
APA
Chicago
ICMJE
MLA
NLM
Baker, E. K., Derry, A., Cohen, J. L., & Chang, I. J. (2025). Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 3. https://doi.org/10.1016/j.gimo.2025.103444
Baker, E. K., A. Derry, J. L. Cohen, and I. J. Chang. “Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).” Genetics in Medicine Open 3 (January 1, 2025). https://doi.org/10.1016/j.gimo.2025.103444.
Baker EK, Derry A, Cohen JL, Chang IJ. Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2025 Jan 1;3.
Baker, E. K., et al. “Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).” Genetics in Medicine Open, vol. 3, Jan. 2025. Scopus, doi:10.1016/j.gimo.2025.103444.
Baker EK, Derry A, Cohen JL, Chang IJ. Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2025 Jan 1;3.
Published In
Genetics in Medicine Open
DOI
EISSN
2949-7744
Publication Date
January 1, 2025
Volume
3